{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T08:10:36Z","timestamp":1786867836279,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Schleswig-Holstein - Campus Kiel"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There is no current standard of anaesthetic management for CA of VT. Data on VT ablation under deep sedation with propofol and fentanyl are limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The aim was to evaluate the feasibility and safety of CA of VT under deep sedation with propofol and fentanyl.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Data from 134 procedures in 106 patients undergoing CA for VT under sedation with propofol and fentanyl were prospectively included. Three groups were defined and compared: group 1 (no VT induction,\n                      <jats:italic>n<\/jats:italic>\n                      =36); group 2 (induction of hemodynamically unstable VT,\n                      <jats:italic>n<\/jats:italic>\n                      =42), and group 3 (induction of hemodynamically stable VT,\n                      <jats:italic>n<\/jats:italic>\n                      =56).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Median age was 64 years, 84% were male, and 97% had structural heart disease. Group 2 had a higher proportion of patients with DCM (\n                      <jats:italic>p<\/jats:italic>\n                      =0.04) and severely reduced LVEF (\n                      <jats:italic>p<\/jats:italic>\n                      =0.024). Unipolar RF ablation was performed in 95% of procedures, bipolar in 12%, and alcohol ablation in 4%. Epicardial access was utilized in 18%. Radiation dose was higher in group 2 (\n                      <jats:italic>p<\/jats:italic>\n                      =0.04), while post-ablation non-inducibility was more frequently achieved in group 3 (\n                      <jats:italic>p<\/jats:italic>\n                      =0.045). There were no cases of profound hypotension or intubation associated with sedation. CPR was performed in seven procedures due to PEA, all in group 2 (\n                      <jats:italic>p<\/jats:italic>\n                      &lt;0.001) with ROSC achieved in all cases within 3 min. No differences were observed in complication rates or hospital stay.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CA for VT under deep sedation with propofol and fentanyl in patients with structural heart disease is feasible and safe, irrespective of VT induction, mapping, and ablation approach. Hemodynamic instability, hypotension, and desaturation can be effectively managed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s10840-025-02081-0","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T08:08:05Z","timestamp":1750061285000},"page":"1845-1856","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Safety of ventricular tachycardia ablation under deep sedation with propofol and fentanyl"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0647-767X","authenticated-orcid":false,"given":"Vera","family":"Maslova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Kannenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustin","family":"Uckermark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius","family":"Nebendahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Cl\u00fcver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Srouji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara","family":"Scherkus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derk","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"2081_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1513614","volume":"375","author":"JL Sapp","year":"2016","unstructured":"Sapp JL, et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med. 2016;375:111\u201321.","journal-title":"N Engl J Med"},{"key":"2081_CR2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.15420\/aer.2015.4.3.177","volume":"4","author":"JJ Liang","year":"2015","unstructured":"Liang JJ, Santangeli P, Callans DJ. Long-term outcomes of ventricular tachycardia ablation in different types of structural heart disease. Arrhythmia Electrophysiol Rev. 2015;4:177.","journal-title":"Arrhythmia Electrophysiol Rev"},{"key":"2081_CR3","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.hrthm.2016.03.004","volume":"13","author":"P Santangeli","year":"2016","unstructured":"Santangeli P, et al. Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis of randomized controlled trials. Heart Rhythm. 2016;13:1552\u20139.","journal-title":"Heart Rhythm"},{"key":"2081_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ccep.2016.10.012","volume":"9","author":"JJ Liang","year":"2017","unstructured":"Liang JJ, Muser D, Santangeli P. Ventricular tachycardia ablation clinical trials. Card Electrophysiol Clin. 2017;9:153\u201365.","journal-title":"Card Electrophysiol Clin"},{"key":"2081_CR5","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","volume":"43","author":"K Zeppenfeld","year":"2022","unstructured":"Zeppenfeld K, et al. ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43:3997\u20134126. https:\/\/doi.org\/10.1093\/eurheartj\/ehac262.","journal-title":"Eur Heart J"},{"key":"2081_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ijcard.2013.12.175","volume":"172","author":"A Wutzler","year":"2014","unstructured":"Wutzler A, et al. Minimal and deep sedation during ablation of ventricular tachycardia. Int J Cardiol. 2014;172:161\u20134.","journal-title":"Int J Cardiol"},{"key":"2081_CR7","doi-asserted-by":"publisher","unstructured":"Ramoul K, et al. Conscious sedation with sufentanil and midazolam for epicardial VT ablation.  https:\/\/doi.org\/10.19102\/icrm.2012.03070.","DOI":"10.19102\/icrm.2012.03070"},{"key":"2081_CR8","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/j.1540-8167.2010.01889.x","volume":"22","author":"JE Mandel","year":"2011","unstructured":"Mandel JE, Hutchinson MD, Marchlinski FE. Remifentanil-midazolam sedation provides hemodynamic stability and comfort during epicardial ablation of ventricular tachycardia. J Cardiovasc Electrophysiol. 2011;22:464\u20136.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"6","key":"2081_CR9","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/0002-9149(91)90352-l","volume":"68","author":"C Hief","year":"1991","unstructured":"Hief C, Borggrefe M, Chen X, Martinez-Rubio A, Hachenberg T, Lawin P, Breithardt G. Effects of enflurane on inducibility of ventricular tachycardia. Am J Cardiol. 1991;68(6):609\u201313. https:\/\/doi.org\/10.1016\/0002-9149(91)90352-l.","journal-title":"Am J Cardiol"},{"key":"2081_CR10","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.hrthm.2015.06.018","volume":"12","author":"E Nof","year":"2015","unstructured":"Nof E, et al. Impact of general anesthesia on initiation and stability of VT during catheter ablation. Heart Rhythm. 2015;12:2213\u201320.","journal-title":"Heart Rhythm"},{"key":"2081_CR11","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/europace\/euz132","volume":"21","author":"EM Cronin","year":"2019","unstructured":"Cronin EM, et al. 2019 HRS\/EHRA\/APHRS\/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Europace. 2019;21:1143\u20134.","journal-title":"Europace"},{"key":"2081_CR12","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1161\/CIRCEP.114.002155","volume":"8","author":"P Santangeli","year":"2015","unstructured":"Santangeli P, et al. Acute hemodynamic decompensation during catheter ablation of scar-related ventricular tachycardia: incidence, predictors, and impact on mortality. Circ Arrhythm Electrophysiol. 2015;8:68\u201375.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2081_CR13","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1053\/j.jvca.2023.12.021","volume":"38","author":"RS Dada","year":"2024","unstructured":"Dada RS, et al. Anesthetic management for ventricular tachycardia ablation: a national anesthesia clinical outcomes registry analysis. J Cardiothorac Vasc Anesth. 2024;38:675\u201382.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2081_CR14","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/europace\/eut025","volume":"15","author":"A Wutzler","year":"2013","unstructured":"Wutzler A, et al. Effects of deep sedation on cardiac electrophysiology in patients undergoing radiofrequency ablation of supraventricular tachycardia: impact of propofol and ketamine. Europace. 2013;15:1019\u201324.","journal-title":"Europace"},{"key":"2081_CR15","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1111\/j.1540-8167.2011.02120.x","volume":"22","author":"H Kottkamp","year":"2011","unstructured":"Kottkamp H, et al. Deep sedation for catheter ablation of atrial fibrillation: a prospective study in 650 consecutive patients. J Cardiovasc Electrophysiol. 2011;22:1339\u201343.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2081_CR16","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1093\/europace\/euab154","volume":"23","author":"R Garcia","year":"2021","unstructured":"Garcia R, et al. Worldwide sedation strategies for atrial fibrillation ablation: Current status and evolution over the last decade. Europace. 2021;23:2039\u201345.","journal-title":"Europace"},{"key":"2081_CR17","doi-asserted-by":"crossref","unstructured":"Massalha E, et al. Comparative analysis of anaesthesia modalities in pulmonary vein isolation: insights from a prospective multicentre registry. Europace. 2025;27.","DOI":"10.1093\/europace\/euae301"},{"key":"2081_CR18","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1111\/jce.14143","volume":"30","author":"RD Anderson","year":"2019","unstructured":"Anderson RD, et al. Ten-year trends in catheter ablation for ventricular tachycardia vs other interventional procedures in Australia. J Cardiovasc Electrophysiol. 2019;30:2353\u201361.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2081_CR19","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.jacep.2018.06.020","volume":"4","author":"OK Yousuf","year":"2018","unstructured":"Yousuf OK, et al. Trends and outcomes of catheter ablation for ventricular tachycardia in a community cohort. JACC Clin Electrophysiol. 2018;4:1189\u201399.","journal-title":"JACC Clin Electrophysiol"},{"key":"2081_CR20","doi-asserted-by":"publisher","unstructured":"Rajagopalan B, et al. Management of anesthesia for procedures in the cardiac electrophysiology laboratory. Heart Rhythm. 2024. https:\/\/doi.org\/10.1016\/j.hrthm.2024.06.048.","DOI":"10.1016\/j.hrthm.2024.06.048"},{"key":"2081_CR21","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1093\/bja\/aew126","volume":"116","author":"F De Wit","year":"2016","unstructured":"De Wit F, et al. The effect of propofol on haemodynamics: cardiac output, venous return, mean systemic filling pressure, and vascular resistances. Br J Anaesth. 2016;116:784\u20139.","journal-title":"Br J Anaesth"},{"key":"2081_CR22","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/bja\/58.9.969","volume":"58","author":"H Stephan","year":"1986","unstructured":"Stephan H, Sonntag H, Schenk HD, Kettler D, Khambatta HJ. Effects of propofol on cardiovascular dynamics, myocardial blood flow and myocardial metabolism in patients with coronary artery disease. Br J Anaesth. 1986;58:969\u201375.","journal-title":"Br J Anaesth"},{"key":"2081_CR23","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1093\/europace\/euv303","volume":"18","author":"H Servatius","year":"2016","unstructured":"Servatius H, et al. Propofol sedation administered by cardiologists for patients undergoing catheter ablation for ventricular tachycardia. Europace. 2016;18:1245\u201351.","journal-title":"Europace"},{"key":"2081_CR24","doi-asserted-by":"publisher","first-page":"282","DOI":"10.15420\/aer.2018.36.3","volume":"7","author":"D Muser","year":"2018","unstructured":"Muser D, Castro SA, Liang JJ, Santangeli P. Identifying risk and management of acute haemodynamic decompensation during catheter ablation of ventricular tachycardia. Arrhythmia Electrophysiol Rev. 2018;7:282\u20137. https:\/\/doi.org\/10.15420\/aer.2018.36.3.","journal-title":"Arrhythmia Electrophysiol Rev"},{"key":"2081_CR25","doi-asserted-by":"crossref","unstructured":"Stojadinovi\u0107 P et al. Periprocedural acute haemodynamic decompensation during substrate-based ablation of scar-related ventricular tachycardia: a rare and unpredictable event. Europace. 2024;26.","DOI":"10.1093\/europace\/euae145"},{"key":"2081_CR26","unstructured":"Stogiannou D, Protopapas A, Tziomalos K. Is propofol the optimal sedative in gastrointestinal endoscopy?."},{"key":"2081_CR27","doi-asserted-by":"publisher","unstructured":"Wang D, Chen C, Chen J, Xu Y, Wang L, Zhu Z, Deng D, Chen J, Long A, Tang D, Liu J. The use of propofol as a sedative agent in gastrointestinal endoscopy: a meta-analysis. PLoS One. 2013;8(1):e53311. https:\/\/doi.org\/10.1371\/journal.pone.0053311.","DOI":"10.1371\/journal.pone.0053311"},{"key":"2081_CR28","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/europace\/eur328","volume":"14","author":"TV Salukhe","year":"2012","unstructured":"Salukhe TV, et al. Propofol sedation administered by cardiologists without assisted ventilation for long cardiac interventions: an assessment of 1000 consecutive patients undergoing atrial fibrillation ablation. Europace. 2012;14:325\u201330.","journal-title":"Europace"},{"issue":"3","key":"2081_CR29","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.hroo.2022.02.011","volume":"O2","author":"L Foerschner","year":"2022","unstructured":"Foerschner L, et al. Deep sedation with propofol in patients undergoing left atrial ablation procedures\u2014is it safe? Heart Rhythm. 2022;02(3):288\u201394.","journal-title":"Heart Rhythm"},{"key":"2081_CR30","doi-asserted-by":"publisher","first-page":"e470","DOI":"10.1016\/j.crvasa.2015.10.002","volume":"57","author":"T Sk\u00e1la","year":"2015","unstructured":"Sk\u00e1la T, T\u00e1borsk\u00fd M. Electromechanical mapping in electrophysiology and beyond. Cor et Vasa. 2015;57:e470\u201382. https:\/\/doi.org\/10.1016\/j.crvasa.2015.10.002.","journal-title":"Cor et Vasa"},{"key":"2081_CR31","unstructured":"Conti S, Sabatino F, Cascino A, Ferrara G, Sgarito G. Dexmedetomidine for sedation during epicardial ablation for ventricular tachycardia: a single-center experience. J Interv Card Electrophysiol. 1:3."},{"key":"2081_CR32","doi-asserted-by":"publisher","unstructured":"Futyma P, Sultan A, Zar\u0119bski \u0141, Imnadze G, Maslova V, Bordignon S, Kousta M, Knecht S, Pavlovi\u0107 N, Peichl P, Lian E, Kueffer T, Scherr D, Pfeffer M, Moskal P, Cismaru G, Antoli\u010d B, Wa\u0142ek P, Chen S, Martinek M, Kollias G, Derndorfer M, Seidl S, Schmidt B, L\u00fcker J, Steven D, Sommer P, Jastrz\u0119bski M, Kautzner J, Reichlin T, Sticherling C, P\u00fcrerfellner H, Enriquez A, W\u00f6rmann J, Chun JKR. Bipolar radiofrequency ablation of refractory ventricular arrhythmias: results from a multicentre network. Europace. 2024;26(10):euae248. https:\/\/doi.org\/10.1093\/europace\/euae248.","DOI":"10.1093\/europace\/euae248"},{"key":"2081_CR33","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.jacep.2018.06.014","volume":"4","author":"K Zeppenfeld","year":"2018","unstructured":"Zeppenfeld K. Ventricular tachycardia ablation in nonischemic cardiomyopathy. JACC Clin Electrophysiol. 2018;4:1123\u201340. https:\/\/doi.org\/10.1016\/j.jacep.2018.06.014.","journal-title":"JACC Clin Electrophysiol"},{"issue":"1","key":"2081_CR34","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12871-021-01503-6","volume":"21","author":"H Dong","year":"2021","unstructured":"Dong H, Li N, Sun Z. The effect of anesthesia depth on radiofrequency catheter ablation of ventricular tachycardia: a retrospective study. BMC Anesthesiol. 2021;21(1):285. https:\/\/doi.org\/10.1186\/s12871-021-01503-6.","journal-title":"BMC Anesthesiol."},{"key":"2081_CR35","doi-asserted-by":"publisher","unstructured":"Freedman BL, et al. Clinical outcomes after ventricular tachycardia ablation with or without induction. Heart Rhythm. 2024;02. https:\/\/doi.org\/10.1016\/j.hroo.2024.10.023.","DOI":"10.1016\/j.hroo.2024.10.023"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-025-02081-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-025-02081-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-025-02081-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T16:02:30Z","timestamp":1764000150000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10840-025-02081-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":35,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2081"],"URL":"https:\/\/doi.org\/10.1007\/s10840-025-02081-0","relation":{},"ISSN":["1572-8595"],"issn-type":[{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the authors did not use any AI services.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}